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Abstract: We still do not know the cause(s) of Behçet syndrome. Most probably several, separate disease mechanisms are involved. I,
like some others, propose we call it not a disease but a syndrome, a construct with a list of strong and weak elements. I like to think
that this frank admission of our ignorance of its cause(s) will be an important semantic stimulus for more meaningful research.

The pathologic entity first described by Hulusi Behçet
in 1937 [1] is more commonly called a disease rather than
a syndrome, as some students of this condition, like me,
like to call it. Webster’s dictionary [2] defines a disease as
a disorder of structure or function in a human, animal, or
plant, especially one that produces specific signs or symptoms
or that affects a specific location and is not simply a direct
result of physical injury while this authoritative source
describes a syndrome as a group of signs and symptoms that
occur together and characterize a particular abnormality
or condition. What is lacking in these definitions is the
place of causality. While a disease may or may not have a
cause, the medical profession most commonly associates a
syndrome with an unknown causality. Finally a construct
is a theoretical entity [2] and a hypothesis that our mind
makes. My last comment in this introduction in the light
of these quotes from Webster’s, I am sure boring to some,
my title would come as a tautology. Well, it is intended to
be. I simply want to emphasize that we still do not what
causes Behçet syndrome (Bsy) and need to be a splitter to
decipher the cause (s) of the construct we have made thus
far. This is not only an intellectual exercise but to better to
take care of our patients.
As we have recently summarized the construct of Bsy
has strong and weak elements [3] like any other construct
before it becomes a construction. I propose that there are 4
strong and 4 weak such elements.
The strong elements: Frequent oral ulceration is a
strong element the absence of which very strongly suggests
another condition. On the other hand, the remaining 3
elements are very specific for Bsy. Our group had initially
shown this many years ago, where in factor analysis it had
shown this as a disease defining aspect [4]. More recently
it was formally shown that some peculiar characteristics

of retinal disease enable ophthalmologists to classify even
from retinal photographs of Bsy patients without knowing
what else a patient has [5]. These characteristics include
a smooth-layered hypopyon, superficial retinal infiltrate
with retinal hemorrhages, and branch retinal vein
occlusion with vitreous haze.
The genital ulcerations were the most specific feature
in the classification criteria we had formulated some years
ago, still widely used [6]. Interestingly, in the male, they are
almost always located on the scrotum, the skin of which is
probably the most testosterone sensitive tissue in the body.
In Behçet syndrome endemic areas noting genital scars,
unless the patient gives another specific reason for their
presence is a very specific finding.
Major vascular disease is another strong element. Bsy
is almost unique among the vasculitides to involve vessels
of all sizes. If one considers only deep and superficial vein
thromboses (DVTs and SVTs) about 1/3 of the patients
have them. The involvement of larger vessels like the
vena cavae and pulmonary arteries is around 5%. On the
other hand, the vasculitis in Bsy is peculiar in that may be
different sites of the vascular tree are involved at the same
time and this is particularly true for venous disease. For
example the presence of dural sinus thrombi, pulmonary
artery aneurysms (reminding ourselves that pulmonary
arteries are very similar to veins both structurally and
by their content), venae caval disease, DVT and SVT
frequently cluster in the same patient [7]. This is a pattern
not perhaps at all observed in other vasculitides.
The pattern of nervous system involvement is the
last strong element. To start with peripheral neuropathy
commonly seen in other primary and secondary
vasculitides is most uncommon. The parenchymal, making
up of 80% of central nervous system disease, the remainder
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is dural sinus thrombi, is a unique vasculopathy of patches
of inflammatory cell accumulation characteristically in
the brain stem. We call this a vasculopathy since a frank
vascular wall inflammation, again common among other
vasculitides, is not seen.
The weak elements: These are made up of the distinctly
peculiar geographic distribution, the different clusters of
disease subsets [8,9], the singular difficulty to tell intestinal
involvement in Bsy from Crohn`s disease unless our
patient has other unique extra-intestinal manifestations
and finally the differing efficacy of different drugs in
different organ manifestations (for example, colchicine has
almost no effect on eye disease while it is rather effective
in arthritis and e. nodosum). These weak elements suggest
that we are dealing with a syndrome rather than a disease
in what was described by Hulusi Behçet back in 1937 [1]
and most probably more than one disease mechanism is
at hand.
Future work: There is good consensus among the
disease, syndrome or construct callers that we still do not

know the cause(s) of Bsy. Here, I humbly suggest that we
give much more attention in our research efforts to what
earlier I mentioned as the strong elements. In this line, I
am gratified to see that recently 2 separate, one from ours,
groups reported that venous wall is diseased among Bsy
patients even when they have no clinical vascular disease
[10,11]. However this is obviously quite preliminary.
We need to know much more about the pathology in
the venous wall in greater depth, in its biochemical,
inflammatory/immunologic and genetic aspects soberly
reminding ourselves that the venous wall has always been
the stepchild of the basic researchers as compared to the
arterial wall.
Finally, we should in general aim at deciphering how
Bsy syndrome differs from other nosologic entities rather
than how it goes cozy with them [12,13]. This is why in this
short communication I initially gave a somewhat boring
emphasis on semantics. I simply wanted to emphasize that
our admitted ignorance should be our semantic stimulus
to understand Bsy better.

References
1.

Behçet H. Uber rezidiverende, aphthose, durch ein Virus
verursachte Gescgwure am Mund, am Auge und an den
Genitalen. Dermatologische Wochenschrift 1937; 105: 11521157 (in German).

2.

Merriam-Webster Dictionary. Available online at https://
www.merriam-webster.com/dictionary/dictionary. accesssed
December 30, 2019.

3.

Yazici H, Seyahi E, Hatemi G, Yazici Y. Behçet syndrome: a
contemporary view. Nature Reviews Rheumatology 2018; 14
(2): 107-119.doi: 10.1038/nrrheum.2017.208

4.

Tunc R, Keyman E, Melikoglu M, Fresko I, Yazici H. Target
organ associations in Turkish patients with Behçet’s disease:
a cross sectional study by exploratory factor analysis. The
Journal of Rheumatology 2002; 29 (11): 2393-2396.

5.

Tugal-Tutkun I, Onal S, Ozyazgan Y, Soylu M, Akman M.
Validity and agreement of uveitis experts in interpretation of
ocular photographs for diagnosis of Behçet uveitis. Ocular
Immunology and Inflammation 2014: 2 (6): 461-468. doi:
10.3109/09273948.2013.854393

6.

International Study Group for Behçet’s Disease. Criteria for
diagnosis of Behçet’s disease. Lancet 1990; 335 (8697): 10781080.

7.

Tascilar K, Melikoglu M, Ugurlu S, Sut N, Caglar E et al. Vascular
involvement in Behçet’s syndrome: a retrospective analysis of
associations and the time course. Rheumatology (Oxford) 2014:
53 (11); 2018-2022. doi: 10.1093/rheumatology/keu233

1586

8.

Yazici H, Ugurlu S, Seyahi E. Behçet syndrome: is it one
condition? Clinical Reviews in Allergy and Immunology 2012;
43 (3): 275-280. doi:10.1007/s12016-012-8319-x

9.

Hatemi G, Fresko I, Tascilar K, Yazici H. Increased enthesopathy
among Behçet’s syndrome patients with acne and arthritis: an
ultrasonography study. Arthritis and Rheumatism 2008; 58 (5):
1539-1545. doi: 10.1002/art.23450

10.

Seyahi E, Gjoni M, Durmaz EŞ, Akbaş S, Sut N et al. Increased
vein wall thickness in Behçet disease. Journal of Vascular
Surgery: Venous and Lymphatic Disorders 2019; 7 (5): 677684.e2. doi: 10.1016/j.jvsv.2018.11.006

11.

Alibaz-Oner F, Ergelen R, Mutis A, Erturk Z, Asadov R et al.
Venous vessel wall thickness in lower extremity is increased
in male patients with Behcet’s disease. Clinical Rheumatology
2019; 38 (5): 1447-1451.doi: 10.1007/s10067-019-04470-z

12.

Moll JMH, Haslock I, Macrae IF, Wright V. Associations between
ankylosing spondylitis, psoriatic arthritis, Reiter’s disease, the
intestinal arthropathies, and Behcet’s syndrome. Medicine
(Baltimore) 1974; 53 (5): 343-364. doi: 10.1097/00005792197409000-00002

13.

McGonagle D, Aydin SZ, Gül A., Mahr A, Direskeneli H.
‘MHC-I-opathy’-unified concept for spondyloarthritis and
Behçet disease. Nature Reviews Rheumatology 2015; 11 (12):
731-740. doi: 10.1038/nrrheum.2015.147

